Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.
NCT07426653
·
clinicaltrials.gov ↗
COMPLETED
Status
298
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Sponsor
Florence Nightingale Hospital, Istanbul